Does the media favor STAA or PLSE?

In the previous week, STAAR Surgical had 27 more articles in the media than Pulse Biosciences. MarketBeat recorded 34 mentions for STAAR Surgical and 7 mentions for Pulse Biosciences. Pulse Biosciences' average media sentiment score of 0.59 beat STAAR Surgical's score of 0.57 indicating that Pulse Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STAAR Surgical 7 Very Positive mention(s) 10 Positive mention(s) 14 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Pulse Biosciences 0 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor STAA or IRTC?

In the previous week, STAAR Surgical had 28 more articles in the media than iRhythm Technologies. MarketBeat recorded 34 mentions for STAAR Surgical and 6 mentions for iRhythm Technologies. STAAR Surgical's average media sentiment score of 0.57 beat iRhythm Technologies' score of 0.42 indicating that STAAR Surgical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STAAR Surgical 7 Very Positive mention(s) 10 Positive mention(s) 14 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive iRhythm Technologies 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better earnings and valuation, TMDX or STAA?

TransMedics Group has higher revenue and earnings than STAAR Surgical. TransMedics Group is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TransMedics Group $605.49M 4.80 $190.29M $3.89 21.61 STAAR Surgical $239.44M 4.70 -$80.45M $0.07 320.43

Does the media prefer TMDX or STAA?

In the previous week, STAAR Surgical had 24 more articles in the media than TransMedics Group. MarketBeat recorded 34 mentions for STAAR Surgical and 10 mentions for TransMedics Group. STAAR Surgical's average media sentiment score of 0.57 beat TransMedics Group's score of 0.42 indicating that STAAR Surgical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TransMedics Group 1 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral STAAR Surgical 7 Very Positive mention(s) 10 Positive mention(s) 14 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, STAA or ATRC?

AtriCure has higher revenue and earnings than STAAR Surgical. AtriCure is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio STAAR Surgical $239.44M 4.70 -$80.45M $0.07 320.43 AtriCure $534.53M 5.52 -$11.45M $0.21 276.43

Does the media favor STAA or ATRC?

In the previous week, STAAR Surgical had 23 more articles in the media than AtriCure. MarketBeat recorded 34 mentions for STAAR Surgical and 11 mentions for AtriCure. AtriCure's average media sentiment score of 0.71 beat STAAR Surgical's score of 0.57 indicating that AtriCure is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STAAR Surgical 7 Very Positive mention(s) 10 Positive mention(s) 14 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AtriCure 5 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to BFLY or STAA?

In the previous week, STAAR Surgical had 21 more articles in the media than Butterfly Network. MarketBeat recorded 34 mentions for STAAR Surgical and 13 mentions for Butterfly Network. Butterfly Network's average media sentiment score of 0.60 beat STAAR Surgical's score of 0.57 indicating that Butterfly Network is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Butterfly Network 6 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive STAAR Surgical 7 Very Positive mention(s) 10 Positive mention(s) 14 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

STAAR Surgical (STAA) Competitors

$22.43 +1.56 (+7.47%)

Closing price 09/29/2026 04:00 PM Eastern

Extended Trading

$22.03 -0.40 (-1.77%)

As of 05:40 AM Eastern

Compare

STAA vs. PLSE, IRTC, TMDX, ATRC, and BFLY

Should you buy STAAR Surgical stock or one of its competitors? STAAR Surgical's main competitors and comparable companies include Pulse Biosciences (PLSE), iRhythm Technologies (IRTC), TransMedics Group (TMDX), AtriCure (ATRC), and Butterfly Network (BFLY). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does STAAR Surgical compare to Pulse Biosciences?

STAAR Surgical (NASDAQ:STAA) and Pulse Biosciences (NASDAQ:PLSE) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, dividends, institutional ownership, earnings, valuation and analyst recommendations.

In the previous week, STAAR Surgical had 27 more articles in the media than Pulse Biosciences. MarketBeat recorded 34 mentions for STAAR Surgical and 7 mentions for Pulse Biosciences. Pulse Biosciences' average media sentiment score of 0.59 beat STAAR Surgical's score of 0.57 indicating that Pulse Biosciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
STAAR Surgical	7 Very Positive mention(s)	10 Positive mention(s)	14 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Pulse Biosciences	0 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Pulse Biosciences has lower revenue, but higher earnings than STAAR Surgical. Pulse Biosciences is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
STAAR Surgical	$239.44M	4.70	-$80.45M	$0.07	320.43
Pulse Biosciences	$350K	10,294.32	-$72.78M	-$1.18	N/A

STAAR Surgical has a beta of 1.21, suggesting that its share price is 21% more volatile than the broader market. Comparatively, Pulse Biosciences has a beta of 1.63, suggesting that its share price is 63% more volatile than the broader market.

96.7% of STAAR Surgical shares are held by institutional investors. Comparatively, 77.0% of Pulse Biosciences shares are held by institutional investors. 39.9% of STAAR Surgical shares are held by insiders. Comparatively, 74.0% of Pulse Biosciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

STAAR Surgical has a net margin of 1.13% compared to Pulse Biosciences' net margin of -6,755.78%. STAAR Surgical's return on equity of 9.05% beat Pulse Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
STAAR Surgical	1.13%	9.05%	6.99%
Pulse Biosciences	-6,755.78%	-94.42%	-79.96%

STAAR Surgical presently has a consensus price target of $28.45, suggesting a potential upside of 26.86%. Pulse Biosciences has a consensus price target of $50.20, suggesting a potential downside of 1.36%. Given STAAR Surgical's higher probable upside, research analysts clearly believe STAAR Surgical is more favorable than Pulse Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
STAAR Surgical	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08
Pulse Biosciences	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.86

Summary

STAAR Surgical beats Pulse Biosciences on 9 of the 17 factors compared between the two stocks.

How does STAAR Surgical compare to iRhythm Technologies?

STAAR Surgical (NASDAQ:STAA) and iRhythm Technologies (NASDAQ:IRTC) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, dividends, analyst recommendations, risk, profitability, media sentiment and institutional ownership.

96.7% of STAAR Surgical shares are owned by institutional investors. 39.9% of STAAR Surgical shares are owned by company insiders. Comparatively, 1.0% of iRhythm Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

iRhythm Technologies has higher revenue and earnings than STAAR Surgical. iRhythm Technologies is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
STAAR Surgical	$239.44M	4.70	-$80.45M	$0.07	320.43
iRhythm Technologies	$825.34M	4.56	-$44.55M	-$0.43	N/A

STAAR Surgical has a net margin of 1.13% compared to iRhythm Technologies' net margin of -1.69%. iRhythm Technologies' return on equity of 10.11% beat STAAR Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
STAAR Surgical	1.13%	9.05%	6.99%
iRhythm Technologies	-1.69%	10.11%	1.53%

STAAR Surgical has a beta of 1.21, meaning that its share price is 21% more volatile than the broader market. Comparatively, iRhythm Technologies has a beta of 1.31, meaning that its share price is 31% more volatile than the broader market.

STAAR Surgical currently has a consensus target price of $28.45, indicating a potential upside of 26.86%. iRhythm Technologies has a consensus target price of $179.93, indicating a potential upside of 57.53%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, analysts plainly believe iRhythm Technologies is more favorable than STAAR Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
STAAR Surgical	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94

In the previous week, STAAR Surgical had 28 more articles in the media than iRhythm Technologies. MarketBeat recorded 34 mentions for STAAR Surgical and 6 mentions for iRhythm Technologies. STAAR Surgical's average media sentiment score of 0.57 beat iRhythm Technologies' score of 0.42 indicating that STAAR Surgical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
STAAR Surgical	7 Very Positive mention(s)	10 Positive mention(s)	14 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
iRhythm Technologies	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

STAAR Surgical beats iRhythm Technologies on 9 of the 17 factors compared between the two stocks.

How does STAAR Surgical compare to TransMedics Group?

TransMedics Group (NASDAQ:TMDX) and STAAR Surgical (NASDAQ:STAA) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, media sentiment, institutional ownership and valuation.

TransMedics Group presently has a consensus target price of $121.10, indicating a potential upside of 44.05%. STAAR Surgical has a consensus target price of $28.45, indicating a potential upside of 26.86%. Given TransMedics Group's stronger consensus rating and higher probable upside, equities research analysts clearly believe TransMedics Group is more favorable than STAAR Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TransMedics Group	1 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.33
STAAR Surgical	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08

99.7% of TransMedics Group shares are held by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are held by institutional investors. 6.9% of TransMedics Group shares are held by insiders. Comparatively, 39.9% of STAAR Surgical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, STAAR Surgical had 24 more articles in the media than TransMedics Group. MarketBeat recorded 34 mentions for STAAR Surgical and 10 mentions for TransMedics Group. STAAR Surgical's average media sentiment score of 0.57 beat TransMedics Group's score of 0.42 indicating that STAAR Surgical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TransMedics Group	1 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
STAAR Surgical	7 Very Positive mention(s)	10 Positive mention(s)	14 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

TransMedics Group has a net margin of 22.69% compared to STAAR Surgical's net margin of 1.13%. TransMedics Group's return on equity of 15.88% beat STAAR Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TransMedics Group	22.69%	15.88%	5.95%
STAAR Surgical	1.13%	9.05%	6.99%

TransMedics Group has higher revenue and earnings than STAAR Surgical. TransMedics Group is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TransMedics Group	$605.49M	4.80	$190.29M	$3.89	21.61
STAAR Surgical	$239.44M	4.70	-$80.45M	$0.07	320.43

TransMedics Group has a beta of 1.9, suggesting that its share price is 90% more volatile than the broader market. Comparatively, STAAR Surgical has a beta of 1.21, suggesting that its share price is 21% more volatile than the broader market.

Summary

TransMedics Group beats STAAR Surgical on 11 of the 16 factors compared between the two stocks.

How does STAAR Surgical compare to AtriCure?

STAAR Surgical (NASDAQ:STAA) and AtriCure (NASDAQ:ATRC) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, profitability, valuation, institutional ownership, analyst recommendations, earnings, risk and dividends.

In the previous week, STAAR Surgical had 23 more articles in the media than AtriCure. MarketBeat recorded 34 mentions for STAAR Surgical and 11 mentions for AtriCure. AtriCure's average media sentiment score of 0.71 beat STAAR Surgical's score of 0.57 indicating that AtriCure is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
STAAR Surgical	7 Very Positive mention(s)	10 Positive mention(s)	14 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AtriCure	5 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

96.7% of STAAR Surgical shares are owned by institutional investors. Comparatively, 99.1% of AtriCure shares are owned by institutional investors. 39.9% of STAAR Surgical shares are owned by insiders. Comparatively, 4.0% of AtriCure shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

AtriCure has a net margin of 1.85% compared to STAAR Surgical's net margin of 1.13%. STAAR Surgical's return on equity of 9.05% beat AtriCure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
STAAR Surgical	1.13%	9.05%	6.99%
AtriCure	1.85%	2.34%	1.77%

STAAR Surgical currently has a consensus price target of $28.45, suggesting a potential upside of 26.86%. AtriCure has a consensus price target of $53.30, suggesting a potential downside of 8.18%. Given STAAR Surgical's higher possible upside, research analysts clearly believe STAAR Surgical is more favorable than AtriCure.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
STAAR Surgical	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08
AtriCure	0 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.75

AtriCure has higher revenue and earnings than STAAR Surgical. AtriCure is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
STAAR Surgical	$239.44M	4.70	-$80.45M	$0.07	320.43
AtriCure	$534.53M	5.52	-$11.45M	$0.21	276.43

STAAR Surgical has a beta of 1.21, indicating that its share price is 21% more volatile than the broader market. Comparatively, AtriCure has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market.

Summary

AtriCure beats STAAR Surgical on 11 of the 17 factors compared between the two stocks.

How does STAAR Surgical compare to Butterfly Network?

Butterfly Network (NYSE:BFLY) and STAAR Surgical (NASDAQ:STAA) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings.

STAAR Surgical has a net margin of 1.13% compared to Butterfly Network's net margin of -66.74%. STAAR Surgical's return on equity of 9.05% beat Butterfly Network's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Butterfly Network	-66.74%	-33.99%	-22.96%
STAAR Surgical	1.13%	9.05%	6.99%

Butterfly Network has higher earnings, but lower revenue than STAAR Surgical. Butterfly Network is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Butterfly Network	$97.61M	24.81	-$77.06M	-$0.29	N/A
STAAR Surgical	$239.44M	4.70	-$80.45M	$0.07	320.43

Butterfly Network presently has a consensus target price of $8.54, indicating a potential downside of 6.09%. STAAR Surgical has a consensus target price of $28.45, indicating a potential upside of 26.86%. Given STAAR Surgical's higher possible upside, analysts plainly believe STAAR Surgical is more favorable than Butterfly Network.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Butterfly Network	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
STAAR Surgical	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08

37.9% of Butterfly Network shares are owned by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are owned by institutional investors. 22.0% of Butterfly Network shares are owned by insiders. Comparatively, 39.9% of STAAR Surgical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, STAAR Surgical had 21 more articles in the media than Butterfly Network. MarketBeat recorded 34 mentions for STAAR Surgical and 13 mentions for Butterfly Network. Butterfly Network's average media sentiment score of 0.60 beat STAAR Surgical's score of 0.57 indicating that Butterfly Network is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Butterfly Network	6 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
STAAR Surgical	7 Very Positive mention(s)	10 Positive mention(s)	14 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Butterfly Network has a beta of 2.08, meaning that its share price is 108% more volatile than the broader market. Comparatively, STAAR Surgical has a beta of 1.21, meaning that its share price is 21% more volatile than the broader market.

Summary

STAAR Surgical beats Butterfly Network on 10 of the 16 factors compared between the two stocks.

Get STAAR Surgical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding STAA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

STAA vs. The Competition

Export

Metric	STAAR Surgical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.05B	$5.54B	$7.34B	$13.05B
Dividend Yield	N/A	1.79%	2.52%	14.18%
P/E Ratio	320.47	25.34	273.78	25.68
Price / Sales	4.70	69.35	592.93	67.95
Price / Cash	N/A	32.94	80.06	52.35
Price / Book	3.24	5.72	10.41	6.34
Net Income	-$80.45M	$150.11M	$3.50B	$360.56M
7 Day Performance	13.28%	-1.66%	-1.38%	-1.60%
1 Month Performance	1.45%	-5.28%	-4.14%	-4.10%
1 Year Performance	-16.52%	5.71%	12.62%	3.79%

STAAR Surgical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
STAA STAAR Surgical	3.3233 of 5 stars	$22.43 +7.5%	$28.45 +26.9%	-16.5%	$1.05B	$239.44M	320.47	957	Trending News Analyst Upgrade Buyback Announcement Gap Up
PLSE Pulse Biosciences	1.9387 of 5 stars	$52.99 -0.6%	$45.25 -14.6%	+185.9%	$3.73B	$350K	N/A	116
IRTC iRhythm Technologies	3.4485 of 5 stars	$110.65 +0.2%	$179.93 +62.6%	-32.6%	$3.65B	$747.14M	N/A	2,400
TMDX TransMedics Group	4.5133 of 5 stars	$88.77 +1.7%	$121.10 +36.4%	-25.4%	$3.06B	$605.49M	22.78	898
ATRC AtriCure	2.5444 of 5 stars	$59.15 +1.4%	$53.30 -9.9%	+66.5%	$3.01B	$534.53M	281.43	1,350

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:STAA) was last updated on 9/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

STAAR Surgical (STAA) Competitors

STAA vs. PLSE, IRTC, TMDX, ATRC, and BFLY

How does STAAR Surgical compare to Pulse Biosciences?

Summary

How does STAAR Surgical compare to iRhythm Technologies?

Summary

How does STAAR Surgical compare to TransMedics Group?

Summary

How does STAAR Surgical compare to AtriCure?

Summary

How does STAAR Surgical compare to Butterfly Network?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

STAA vs. The Competition

STAAR Surgical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

STAAR Surgical (STAA) Competitors

STAA vs. PLSE, IRTC, TMDX, ATRC, and BFLY

How does STAAR Surgical compare to Pulse Biosciences?

Does the media favor STAA or PLSE?

Which has stronger earnings and valuation, STAA or PLSE?

Which has more volatility & risk, STAA or PLSE?

Do institutionals & insiders have more ownership in STAA or PLSE?

Is STAA or PLSE more profitable?

Do analysts rate STAA or PLSE?

Summary

How does STAAR Surgical compare to iRhythm Technologies?

Do insiders and institutionals hold more shares of STAA or IRTC?

Which has better valuation and earnings, STAA or IRTC?

Is STAA or IRTC more profitable?

Which has more volatility & risk, STAA or IRTC?

Do analysts prefer STAA or IRTC?

Does the media favor STAA or IRTC?

Summary

How does STAAR Surgical compare to TransMedics Group?

Do analysts prefer TMDX or STAA?

Do institutionals and insiders believe in TMDX or STAA?

Does the media prefer TMDX or STAA?

Is TMDX or STAA more profitable?

Which has better earnings and valuation, TMDX or STAA?

Which has more risk & volatility, TMDX or STAA?

Summary

How does STAAR Surgical compare to AtriCure?

Does the media favor STAA or ATRC?

Do insiders & institutionals believe in STAA or ATRC?

Is STAA or ATRC more profitable?

Do analysts rate STAA or ATRC?

Which has stronger valuation and earnings, STAA or ATRC?

Which has more risk and volatility, STAA or ATRC?

Summary

How does STAAR Surgical compare to Butterfly Network?

Is BFLY or STAA more profitable?

Which has higher valuation & earnings, BFLY or STAA?

Do analysts prefer BFLY or STAA?

Do insiders and institutionals hold more shares of BFLY or STAA?

Does the media refer more to BFLY or STAA?

Which has more risk and volatility, BFLY or STAA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

STAA vs. The Competition

STAAR Surgical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools